What to watch with CYP2D6 and gut health?

CYP2D6 is a key drug-metabolizing enzyme primarily expressed in the liver. A direct link to gut health is not well established. The gut microbiome can influence liver enzyme activity, but evidence for specific effects on CYP2D6 is weak and inconsistent. Some studies suggest that certain gut bacteria produce metabolites that may inhibit or induce CYP2D6, but the evidence is mostly mechanistic, from animal or in vitro models. For consumers, a DNA test for CYP2D6 variants (poor, intermediate, extensive, ultrarapid metabolizer) tells you little about gut health. If you have digestive issues, focus on validated markers (e.g., microbiome diversity, inflammation) rather than CYP2D6. The combination of CYP2D6 and gut health remains a niche area without clinical guidelines. Be cautious of marketing claims that promise personalized diets or gut therapies based solely on CYP2D6.